ClinicalTrials.govpublic full text
Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies
hematological disease, lymphoid malignancies, haematological disease, lymphoid malignancy, histone deacetylase inhibitor, dose escalation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901721
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.